SINOVAC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sinovac Biotech Ltd.

NEW ORLEANS, June 27, 2017 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Sinovac Biotech Ltd ("Sinovac" or the "Company") (NASDAQ: SVA) to Sinovac (Cayman) Limited. Under the terms of the proposed transaction, shareholders of Sinovac will receive only $7.00 in cash for each share of Sinovac that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC
206 Covington St.
Madisonville, LA 70447

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sinovac-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick--foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-sinovac-biotech-ltd-300480748.html

SOURCE Kahn Swick & Foti, LLC